About Pharma Diagnostics
Pharma Diagnostics is a company based in Asse (Belgium) founded in 2007. Pharma Diagnostics has raised $7.4 million across 2 funding rounds from investors including PMV, Cap-E and Capital E. The company has 8 employees. Pharma Diagnostics operates in a competitive market with competitors including Carterra, Nicoya Life, Riot Platforms, FOx Biosystems and Plasmore, among others.
- Headquarter Asse, Belgium
- Employees 8
- SectorsHealthcare
- Website pharmadiagnostics.com
- Social LinkedIn
- Legal Name Pharma Diagnostics
- Total Equity Funding$7.4M (USD)
in 2 rounds
- Latest Funding Round$3.7M (USD), Series B
Jan 2010
- InvestorsPMV
& 3 more
- Employee Count8
Funding Insights of Pharma Diagnostics
Pharma Diagnostics has successfully raised a total of $7.4M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $3.7 million completed in January 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.4M
- Total Rounds 2
- Last Round Series B — $3.7M
- First Round $3.7M
(Oct 2009)
- Investors Count 4
All 2 funding rounds of Pharma Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2010 | $3.7M | Series B | – | – | |
| Oct 2009 | $3.7M | Series A | – | – |
4 investors in total: 4 institutional.
Investors in Pharma Diagnostics
Pharma Diagnostics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include PMV, Cap-E and Capital E.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused early-stage VC firm | – | cap-e.com | Washington, Dc, United States | |
A venture capital fund focused on micro/nano-electronics is operated. | – | capital-e.com | Antwerp, Belgium | |
Allegro Investment Fund is involved in investment activities. | – | allegroinvestmentfund.com | - | |
Private debt funds are managed across multiple sectors. | 2001 | pmv.eu | Brussels, Belgium |
Investor details for Pharma Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pharma Diagnostics
1 people are tracked at Pharma Diagnostics (1 in leadership); the tracked headcount is 8.
| Name | Role | Group |
|---|---|---|
Pierre Saelen | CEO | Leadership |
Complete people profiles for Pharma Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pharma Diagnostics
3 dated milestones of Pharma Diagnostics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Pharma Diagnostics is founded.
- Funding First funding round of $3.7M.
- Funding Latest funding round, Series B, of $3.7M.
Competitors of Pharma Diagnostics
Pharma Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Carterra, Nicoya Life, Riot Platforms, FOx Biosystems and Plasmore, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| carterra-bio.com | 2004 | Salt Lake, United States | $47.22M | – | SPR-based platforms are developed for enzyme kinetics studies. | |
| nicoyalife.com | 2012 | Kitchener, Canada | $27.54M | – | Hyperspectral optical microscopes for surface analysis are provided. | |
| riotplatforms.com | 2000 | Castle Rock, United States | – | 3 | Bitcoin mining solutions are offered by the platform. | |
| foxbiosystems.com | 2017 | Temse, Belgium | $4.53M | 9 | Developer of fiber optic bio-sensing technology based on surface plasmon resonance | |
| plasmore.com | 2009 | Pavia, Italy | – | – | Develops nanoplasmon imaging technology | |
| smartdrop.co.kr | 2014 | Seongnam-si, South Korea | – | – | Electronic devices for interface contact angle measurement are provided. | |
| episentum.com | 2010 | Upplands Vasby, Sweden | – | – | Label-enhanced surface plasmon resonance biosensors are developed for enhanced detection. | |
| affiniteinstruments.com | 2015 | Montreal, Canada | – | – | A portable SPR platform for molecular analysis is developed. | |
| biosensingusa.com | 2015 | Tempe, United States | – | – | Surface analytical instruments for life sciences and materials applications |
Detailed competitors of Pharma Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pharma Diagnostics
Websites that share an audience with Pharma Diagnostics (pharmadiagnostics.com).
Websites whose visitors overlap most with Pharma Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
chemovation.com | chemovation.com | 100% | – | – | – |
nanotherapeutics.com | nanotherapeutics.com | 100% | – | – | – |
pvct.com | pvct.com | 100% | – | – | – |
phytopharm.com | phytopharm.com | 100% | – | – | – |
kinexpharma.com | kinexpharma.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Pharma Diagnostics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Pharma Diagnostics
10 companies that operate in the same segment as Pharma Diagnostics (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharma Diagnostics
Pharma Diagnostics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Pharma Diagnostics is headquartered in Asse, Belgium. It is registered at Asse, Flemish Brabant, Belgium.
Pierre Saelen is the current CEO of Pharma Diagnostics.
Pharma Diagnostics is a funded company, having raised a total of $7.4M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.7M, raised on Oct 2009.
Pharma Diagnostics has 8 employees.
Pharma Diagnostics was founded in 2007 in Asse, Belgium, and operates in the diagnostics sector. A technology platform for biomolecular interaction analysis is offered, centered on the proprietary SoPRano assay. This plate-based LSPR method employs gold nanomaterials conjugated to biomolecules, with absorbance changes detected on standard plate readers upon ligand binding. Applications encompass interaction kinetics, antibody screening, protein-protein interaction studies, and small molecule inhibition assays.
Pharma Diagnostics's top competitors include Carterra, Nicoya Life and Riot Platforms.
Pharma Diagnostics has 4 investors. Key investors include PMV, Cap-E, Capital E, and Allegro Investment Fund.
Pharma Diagnostics operates through Pharma Diagnostics.